Goldman and Jena Discuss the Challenges of Value-Based Pricing in STAT News
In a new commentary for STAT News, PHE co-founder Dana Goldman and scientific advisor Anupam Jena discuss the advantages of value-based pricing, pointing out several of the key challenges that complicate the application of health technology assessments. Goldman and Jena make the case that more transparency is needed and that an open-source model would allow underlying assumptions to be assessed, criticized and modified by all stakeholders.
To read the complete article, please click here.
In this unique one-hour webinar, Dr. Jena outlines a broader framework for assessing value to improve identification of not only the highest-value treatments, but also low-value therapies on which spending can safely be reduced.